Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A randomized controlled trial of a decision aid for women at increased risk of ovarian cancer.

Medical decision making : an international journal of the Society for Medical Decision Making - 1 Jan 2000

Tiller K, Meiser B, Gaff C, Kirk J, Dudding T, Phillips K-A, Friedlander M, Tucker K

Abstract excerpt

PURPOSE: To carry out a randomized controlled trial of a decision aid for women at increased risk of developing ovarian cancer to facilitate decision making regarding risk management options. METHODS: This randomized trial, conducted through 6 familial cancer centers, compared the efficacy of tailored decision aid to that of a general educational pamphlet in preparing women for decision making. PARTICIPANTS: 131...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anxiety
Share to Decision Making

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Decision Support Techniques

Share to Genetic Predisposition to Disease

Share to Ovarian Neoplasms

Share to Patient Education as Topic

Share to Patient Satisfaction

Source

Identifiers

PMID: 16855125
DOI: 10.1177/0272989X06290486

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A randomized controlled trial of a decision aid for women at increased risk of ovarian cancer.PMID 16855125Read ↗

A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk.Semantic proximity Read ↗

Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk.Semantic proximity Read ↗

Impact of a decision aid about stratified ovarian cancer risk-management on women's knowledge and intentions: a randomised online experimental survey study.Semantic proximity Read ↗

Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.Semantic proximity Read ↗

Development and pilot testing of a decision aid for men considering genetic testing for breast and/or ovarian cancer-related mutations (BRCA1/2).Semantic proximity Read ↗

The development of an online decision aid to support persons having a genetic predisposition to cancer and their partners during reproductive decision-making: a usability and pilot study.Semantic proximity Read ↗

Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.Semantic proximity Read ↗

Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Development and Pilot Testing of a Decision Aid for Genomic Research Participants Notified of Clinically Actionable Research Findings for Cancer Risk.Semantic proximity Read ↗

Longitudinal Changes in Patient Distress following Interactive Decision Aid Use among BRCA1/2 CarriersSemantic proximity Read ↗

Development and testing of patient-centered education about hormone replacement therapy for women at high genetic risk of breast and ovarian cancer.Semantic proximity Read ↗

A patient decision aid for risk-reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.